Profile
Lei Fang is currently the Vice President at Lepu Biopharma Co., Ltd. and the General Manager at CtM Bio Co., Ltd. Prior to these roles, Dr. Fang worked as the Director of Research & Development at I-MAB Biopharma Co., Ltd. from 2016 to 2020.
Dr. Fang also served as a Director at Third Venture Biopharma (Nanjing) Co., Ltd. Dr. Fang holds a doctorate degree from the Chinese Academy of Sciences and an undergraduate degree from Hebei University, which was conferred in 2004.
Lei Fang active positions
| Companies | Position | Start |
|---|---|---|
| LEPU BIOPHARMA CO., LTD. | Corporate Officer/Principal | 2020-12-09 |
CtM Bio Co., Ltd. | Chief Executive Officer | - |
Former positions of Lei Fang
| Companies | Position | End |
|---|---|---|
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology Operates as biotechnology company focuses on cancer immunity and autoimmune disease treatment | Chief Tech/Sci/R&D Officer | 2020-03-31 |
Third Venture Biopharma (Nanjing) Co., Ltd. | Director/Board Member | - |
Training of Lei Fang
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Chinese Academy of Sciences
Chinese Academy of Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hebei University
Hebei University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology Operates as biotechnology company focuses on cancer immunity and autoimmune disease treatment | Health Technology |
Lepu Biopharma Co., Ltd.
Lepu Biopharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
CtM Bio Co., Ltd. | |
Third Venture Biopharma (Nanjing) Co., Ltd. |
- Stock Market
- Insiders
- Lei Fang
















